Infectious complications in non-myeloablative conditioning and allogeneic peripheral blood stem cell transplantation for patients with multiple myeloma.

被引：0
|
作者：
Lee, CK
Dignani, C
Barlogie, B
Guido, T
Morris, CL
Badros, AZ
Cottler-Fox, MH
van Rhee, F
Zanagari, M
Fassas, A
Anaissie, EJ
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Hosp Clin Sao Paulo, Sao Paulo, Brazil
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Loma Linda Univ, Med Ctr, Loma Linda, CA 92350 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2471
引用
收藏
页码：627A / 627A
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative allogeneic stem cell transplantation is feasible in multiple myeloma patients with end-stage renal disease.
    Steel, E
    Gadisseur, APA
    Van de Velde, ALR
    Schroyens, WA
    Zachee, P
    Berneman, ZN
    BLOOD, 2003, 102 (11) : 430B - 431B
  • [42] Myeloablative versus non myeloablative stem cell transplant for multiple myeloma.
    Arora, M
    McGlave, PB
    Burns, LJ
    Barker, JN
    Miller, JS
    DeFor, TE
    Weisdorf, DJ
    BLOOD, 2003, 102 (11) : 465B - 466B
  • [43] Pseudothrombocytopenia after allogeneic non-myeloablative stem cell transplantation
    Gillis, S
    Eisenberg, ME
    Shapira, MY
    Or, R
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (09): : 671 - 673
  • [44] Autologous non-myeloablative peripheral blood stem cell transplantation in patients with systemic sclerosis.
    Barr, Walter G.
    Oyama, Yu
    Statkute, Laisvyde
    Corbridge, Thomas
    Yaung, Kimberly
    Quigley, Kathleen
    Verda, Larissa
    Krosnjar, Nela
    Bronesky, Delphine
    Burt, Richard K.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S314 - S314
  • [45] Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: Results of the Mexican approach
    Guillermo J. Ruiz-Argüelles
    International Journal of Hematology, 2002, 76 : 376 - 379
  • [46] Long-term outcome of autologous and myeloablative allogeneic stem cell transplantation for Multiple Myeloma.
    Kuruvilla, J
    Nevill, TJ
    Nitta, J
    Le, A
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Shepherd, JD
    BLOOD, 2003, 102 (11) : 475A - 475A
  • [47] Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia
    Gökbuget, N
    Hoelzer, D
    HAEMATOLOGICA, 2003, 88 (05) : 484 - 486
  • [48] Sinonasal zygomycosis in a patient with myelodysplastic syndrome following non-myeloablative allogeneic peripheral blood stem cell transplantation
    Nakazato, Tetsuro
    Nagasaki, Akitoshi
    Nakayama, Takashi
    Shinhama, Akihiko
    Taira, Naoya
    Takasu, Nobuyuki
    INTERNAL MEDICINE, 2007, 46 (22) : 1881 - 1882
  • [49] Non-Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease
    Saraf, Santosh
    Patel, Pritesh Rajni
    Sweiss, Karen
    Oh, Annie
    Koshy, Matthew
    Campbell-Lee, Sally
    Gowhari, Michel
    Jain, Shivi
    Peace, David
    Quigley, John
    Khan, Irum
    Molokie, Robert
    Mahmud, Nadim
    Gordeuk, Victor
    Rondelli, Damiano
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S59 - S59
  • [50] Allogeneic non-myeloablative peripheral-blood stem cell transplant in solid tumors
    Peccatori, J
    Bregni, M
    TUMORI, 2002, : S32 - S33
12345